Cystic Fibrosis Mutation Screening CFTR – Del 508 G551DR553X G542X Test
Test Cost: AED 1500.0
Symptoms and Diagnosis
Cystic Fibrosis Mutation Screening (CFTR – Del 508, G551D/R553X, G542X) is a genetic test that helps in the diagnosis of cystic fibrosis, a genetic disorder affecting the lungs, pancreas, and other organs. This test looks for specific mutations in the CFTR gene, which is responsible for regulating salt and water movement in and out of cells.
Test Components
- EDTA Vacutainer (2ml)
Price: AED 1500.0
Sample Condition
This test requires a peripheral blood sample for analysis.
Report Delivery
The test results will be delivered within 3-4 days.
Method
The Cystic Fibrosis Mutation Screening CFTR – Del 508 G551DR553X G542X Test is performed using the End Point PCR method.
Test Type
This test falls under the category of Genetics.
Doctor
This test can be requested by a General Physician.
Test Department
This test is conducted in the Genetics department.
Pre Test Information
Cystic Fibrosis Mutation Screening (CFTR – Del 508, G551D/R553X, G542X) can be done with a doctor’s prescription. However, the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Test Details
Cystic Fibrosis Mutation Screening is a genetic test that identifies specific mutations in the CFTR gene. The CFTR – Del 508 mutation is the most common mutation found in individuals with cystic fibrosis. It involves the deletion of a single amino acid (phenylalanine) at position 508 of the CFTR protein, leading to the production of a faulty CFTR protein. The G551D and R553X mutations are two other common mutations in the CFTR gene that result in nonfunctional CFTR proteins. The G542X mutation is also a common mutation that leads to the production of a faulty CFTR protein.
Screening for these specific mutations is crucial for the diagnosis of cystic fibrosis and carrier testing for individuals with a family history of the disease. Identifying these mutations can provide important information for treatment options and family planning.
Test Name | Cystic Fibrosis Mutation Screening CFTR – Del 508 G551DR553X G542X Test |
---|---|
Components | EDTA Vacutainer (2ml) |
Price | 1500.0 AED |
Sample Condition | Peripheral blood |
Report Delivery | 3-4 days |
Method | End Point PCR |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Cystic Fibrosis Mutation Screening (CFTR – Del 508, G551D/R553X, G542X) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
Cystic Fibrosis Mutation Screening is a genetic test that looks for specific mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. This gene provides instructions for making a protein that is involved in the movement of salt and water in and out of cells. Mutations in this gene can lead to the development of cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs. The CFTR – Del 508 mutation is the most common mutation found in individuals with cystic fibrosis. It involves the deletion of a single amino acid (phenylalanine) at position 508 of the CFTR protein. This mutation disrupts the normal function of the protein, leading to the production of a faulty CFTR protein that is unable to regulate salt and water movement properly. The G551D and R553X mutations are two other common mutations found in the CFTR gene. The G551D mutation involves a change in the amino acid at position 551 of the CFTR protein, while the R553X mutation is a nonsense mutation that leads to the premature termination of protein synthesis. Both mutations result in the production of nonfunctional CFTR proteins. The G542X mutation is another common mutation found in individuals with cystic fibrosis. It involves a change in the amino acid at position 542 of the CFTR protein and leads to the production of a faulty CFTR protein. Screening for these specific mutations is important in the diagnosis of cystic fibrosis, as well as in carrier testing for individuals with a family history of the disease. Identifying these mutations can help guide treatment options and provide important information for family planning. |